Fifth Third Bancorp Corcept Therapeutics Inc Transaction History

Fifth Third Bancorp

$28.3 Billion
Q2 2025

A detailed history of Fifth Third Bancorp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 706 shares of CORT stock, worth $62,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

706

Previous 757 6.74%

Holding current value

$62,233

Previous $86,000 40.7%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$62.24 - $91.93 $3,174 - $4,688	-51 Reduced 6.74%	706 $51,000
Q1 2025 Apr 15, 2025	BUY	$49.85 - $114.22 $6,929 - $15,876	139 Added 22.49%	757 $86,000
Q4 2024 Jan 21, 2025	SELL	$44.66 - $60.85 $401 - $547	-9 Reduced 1.44%	618 $31,000
Q3 2024 Oct 17, 2024	BUY	$29.51 - $46.26 $1,741 - $2,729	59 Added 10.39%	627 $29,000
Q2 2024 Jul 22, 2024	BUY	$22.21 - $34.48 $1,799 - $2,792	81 Added 16.63%	568 $18,000
Q1 2024 Apr 23, 2024	BUY	$21.1 - $27.46 $422 - $549	20 Added 4.28%	487 $12,000
Q1 2023 Apr 24, 2023	BUY	$19.2 - $24.47 $2,822 - $3,597	147 Added 45.94%	467 $10,000
Q4 2022 Jan 25, 2023	SELL	$19.95 - $29.96 $957 - $1,438	-48 Reduced 13.04%	320 $0
Q3 2022 Oct 25, 2022	BUY	$24.7 - $29.12 $2,050 - $2,416	83 Added 29.12%	368 $9,000
Q2 2022 Aug 04, 2022	SELL	$17.33 - $25.3 $831 - $1,214	-48 Reduced 14.41%	285 $7,000
Q1 2022 Apr 19, 2022	BUY	$16.53 - $25.21 $3,372 - $5,142	204 Added 158.14%	333 $7,000
Q4 2021 Feb 01, 2022	BUY	$17.1 - $23.34 $478 - $653	28 Added 27.72%	129 $3,000
Q3 2021 Oct 15, 2021	BUY	$19.68 - $22.53 $1,987 - $2,275	101 New	101 $2,000
Q2 2021 Aug 06, 2021	SELL	$19.97 - $24.43 $5,052 - $6,180	-253 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$23.49 - $30.56 $5,942 - $7,731	253 New	253 $6,000
Q1 2019 May 14, 2019	SELL	$10.03 - $15.71 $249,064 - $390,110	-24,832 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $187,639 - $285,697	-16,620 Reduced 40.09%	24,832 $332,000
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $119,031 - $151,820	9,701 Added 30.55%	41,452 $581,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $22,338 - $28,747	-1,460 Reduced 4.4%	31,751 $499,000
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $484,548 - $846,880	33,211 New	33,211 $546,000

Others Institutions Holding CORT

# of Institutions

467

Shares Held

82.8M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $9.44B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Corcept Therapeutics Inc Transaction History